JeffreyNBruceMD
Neurosurgery • New York, NYBrain & Spinal Tumor, Pituitary Surgery, Skull Base
Professor of Neurological Surgery, Columbia P&S
Overview of Dr. Bruce
Dr. Jeffrey Bruce is a neurosurgeon in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 34 years. Dr. Bruce accepts several types of health insurance, listed below. He is one of 109 doctors at New York-Presbyterian Hospital and one of 50 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurosurgery. He has more than 100 publications and over 500 citings.
Office
CUIMC/Neurological Institute of New York
710 West 168th Street
New York, NY 10032- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurological Surgery, 1985 - 1990
Clinical Center at the National Institutes of HealthResidency, Neurological Surgery, 1984 - 1985- New York Presbyterian Hospital (Columbia Campus)Internship, Transitional Year, 1983 - 1984
Rutgers Robert Wood Johnson Medical SchoolClass of 1983
Certifications & Licensure
NJ State Medical License 1993 - 2023
NY State Medical License 1989 - 2024- American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2020
- New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2011-2014, 2017-2020
- America's Top Doctors for Cancer Castle Connolly, 2005-2020
- Join now to see all
Clinical Trials
- Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors Start of enrollment: 2004 Mar 01
- A Phase I Study of Topotecan by Convection Enhanced Delivery (Intracerebral Clysis) for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Sep 01
- A Phase I/II Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors Start of enrollment: 2003 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.Eleonora F Spinazzi, Michael G Argenziano, Pavan S Upadhyayula, Matei A Banu, Justin A Neira, Dominique M O Higgins, Peter B Wu, Brianna Pereira, Aayushi Mahajan, Nels...> ;The Lancet. Oncology. 2022 Nov 1
- Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma.Consuelo Torrini, Trang Thi Thu Nguyen, Chang Shu, Angeliki Mela, Nelson Humala, Aayushi Mahajan, Erin Heather Seeley, Guoan Zhang, Mike-Andrew Westhoff, Georg Karpel-...> ;Molecular cell. 2022 Aug 18
- Dissecting the treatment-naive ecosystem of human melanoma brain metastasis.Jana Biermann, Johannes C Melms, Amit Dipak Amin, Yiping Wang, Lindsay A Caprio, Alcida Karz, Somnath Tagore, Irving Barrera, Miguel A Ibarra-Arellano, Massimo Andreat...> ;Cell. 2022 Jul 7
- Join now to see all
Journal Articles
- De Novo Gene Signature Identification from Single‐Cell RNA‐Seq with Hierarchical Poisson FactorizationPeter Canoll, Jeffrey N Bruce, Molecular Systems Biology
Authored Content
- Recently Viewed (1) Article Information Headings References TrendMD Related Metrics PubMed Google ScholarDecember 2018
- Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-Analysis RelatedApril 2018
- Effectiveness of Perioperative Antiepileptic Drug Prophylaxis for Early and Late Seizures Following Oncologic Neurosurgery: A Meta-AnalysisApril 2018
Press Mentions
Dr. Bruce Lectures on Brain Tumors and Brain Surgery in IndiaMay 30th, 2019- Mentorship and Service at AANS 2018April 30th, 2018
Four Neuro-Oncology Experts to Lead New Glioblastoma Research Center at NewYork-PresbyterianMay 24th, 2017- Join now to see all
Grant Support
- Topotecan By Intracerebral Clysis For Brain TumorsNational Cancer Institute2002–2006
- Topotecan By Intracerebral Clysis /Treatment Of Primary Malignant BraintumorNational Center For Research Resources2005
- Recombinant Chimeric Protein For Recurrent AstrocytomaNational Center For Research Resources2000–2002
- Intratumoral/Interstitial Therapy With Hn-6600 In Refracotry GlioblastomaNational Center For Research Resources1998–2000
- CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1995–1997
- Brain Tumor Research CenterNational Cancer Institute1995
- CNS Consortium--New Approaches To Brain Tumor TherapyNational Cancer Institute1994
- Brain Tumor Research CenterNational Cancer Institute1994
Professional Memberships
- Member
- Member
- Fellow
- Member
- Member
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Choice
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
Lifewise Health Plan of Oregon
Multiplan PHCS PPOMultiplan PPO
MVP Healthcare PPO
ODS Network
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
PacificSource Preferred PSN
Providence Health System Personal Option
Providence Health System Preferred PPO
Regence Oregon - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
